EDGAR Filing Documents for 0001193125-08-107800

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-08-107800

Filing Date

2008-05-08

Accepted

2008-05-08 16:11:23

Documents

Period of Report

2008-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	CORTEX PHARM., INC. FORM 10-Q MARCH 31, 2008	d10q.htm	10-Q	188466
2	AMEND. #3 DATED 04/17/2008 TO CONSULTING AGMT DATED 04/16/2004	dex10106.htm	EX-10.106	5668
3	SEVERANCE AGMT DATED 05/02/2008 BETWEEN COMPANY AND STEVEN JOHNSON	dex10107.htm	EX-10.107	6989
4	CERT. BY CEO AS ADOPTED PURSUANT TO SEC. 302 OF SARBANES-OXLEY ACT OF 2002	dex311.htm	EX-31.1	9304
5	CERT. BY CFO AS ADOPTED PURSUANT TO SEC. 302 OF SARBANES-OXLEY ACT OF 2002	dex312.htm	EX-31.2	9308
6	CERT. PURSUANT TO 18 USC SEC. 1350, AS ADOPTED PURSUANT TO SEC. 906	dex32.htm	EX-32	4053
7	GRAPHIC	g21386ex10107.jpg	GRAPHIC	21863
	Complete submission text file	0001193125-08-107800.txt		255447

Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718

Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157

CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)